2+ hour, 10+ min ago  (157+ words) Med City News A significant number of non-small cell lung cancer patients (NSCLC) patients miss out on optimal care due to gaps in biomarker testing, socioeconomic barriers, and incomplete patient journey data. A new e Book from Purple Lab and…...

17+ hour, 50+ min ago  (295+ words) Insmed drug Brinsupri failed to beat a placebo in a mid-stage clinical trial testing the daily pill as a treatment for hidradenitis suppurativa, a chronic inflammatory skin disorder. Brinsupri is still projected to become a blockbuster seller in non-cystic fibrosis…...

18+ hour, 26+ min ago  (521+ words) Jefferson Health in Philadelphia is suing Aetna over a new Medicare Advantage payment policy that hospitals say unfairly reduces reimbursements for legitimate inpatient stays. The case highlights a broader clash between providers and Medicare Advantage plans over "downcoding" short hospital…...

23+ hour, 41+ min ago  (491+ words) Rural health organizations cannot afford to get dazzled by AI demo candy. There is no such thing as "Fix Healthcare GPT," and investing in the wrong technology for the future isn't going to do anything to improve patient outcomes today....

1+ day, 40+ min ago  (208+ words) What Is Enterprise EHR Software?" Enterprise EHRs provide a connected infrastructure that scales with organizational growth, rather than functioning as isolated systems. Core Features That Make Enterprise EHRs so Powerful Built for Scalability Across Locations and Specialties An API-first integration…...

1+ day, 11+ hour ago  (657+ words) Healthcare leaders can't tell whether value-based care and Medicare Advantage are truly lowering costs. Some see promise in these models and ongoing innovations, while others say the programs haven't delivered measurable savings and point to direct contracting as a more…...

1+ day, 19+ hour ago  (14+ words) Gilead's Pipeline Strategy Takes Shape With $3 B Acquisition of Cancer Biotech Tubulis'Med City News...

2+ day, 11+ hour ago  (457+ words) Digital health funding rebounded in the first quarter of 2026, reaching $4 billion across 110 deals, according to data from Rock Health. The surge was fueled mainly by megadeals, reflecting a market where investors are placing larger bets on fewer startups. After several…...

2+ day, 15+ hour ago  (256+ words) Neurocrine Biosciences is expanding its scope in rare endocrine disorders through the $2. 9 billion acquisition of Soleno Therapeutics, a company that commercialized the first approved drug for a rare genetic condition that leads to ravenous hunger. "What we've seen across thus…...

2+ day, 15+ hour ago  (261+ words) About 25% of healthcare spending goes towards administrative costs, largely due to issues with fragmented systems. This is what Yuzu Health, a third-party administrator, aims to solve, announcing on Monday that it secured $35 million in Series A funding. How to turn…...